# Michael Davis

Type: Person

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/michael-davis
Canonical HTML page: https://gethealthbrief.com/entity/michael-davis

## Timeline

- **2026-09-08**: HHS announces permanent FDA center directors — Four senior positions filled, including permanent directors for drugs, vaccines/biologics, and tobacco products.
- **2026-09-08**: HHS fills four senior FDA roles — The Department of Health and Human Services announced permanent directors for the FDA's drug, vaccine and biologics, and tobacco centers, along with a fourth senior position.
- **2026-05**: Tracy Beth Høeg departs CDER — Høeg says she was fired as director of the FDA's Center for Drug Evaluation and Research.
- **2026-05**: Michael Davis assumes acting CDER director — Davis steps in as acting director of CDER following Høeg's departure.
- **2026-05**: Hoeg departs CDER — Dr. Tracy Beth Hoeg said she was fired from the Center for Drug Evaluation and Research; Davis began serving in an acting role.
- **2025**: Michael Davis returns to FDA as deputy director — Davis rejoins the agency after working at a nonprofit pursuing psychedelic drug development.
- **2025**: Davis returns to FDA — Michael Davis rejoined the agency as a deputy director after working at a nonprofit pursuing psychedelic drug development.

## Recent coverage (2 stories)

### FDA Names 4 Permanent Leaders, Installing Drug, Vaccine, Tobacco Directors
2026-09-09 21:53:37 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

FDA gains stability as HHS fills four senior roles, with permanent directors for drug, vaccine and tobacco centers. The moves follow months of upheaval and could reshape regulatory timelines, safety oversight, and public health policy.
Full story: https://gethealthbrief.com/story/fda-four-senior-leadership-roles-healthcare-oversight-2026

### FDA Fills 4 Senior Roles, Stabilizing Drug, Vaccine, Tobacco Oversight
2026-09-09 16:42:22 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

HHS has made permanent four acting officials at the FDA's drug, vaccine, and tobacco centers, reducing leadership uncertainty for health systems, clinicians, and patients. The moves follow months of controversy and high-profile departures.
Full story: https://gethealthbrief.com/story/fda-four-senior-roles-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.